PMC:7736111 / 109569-109796 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"2510","span":{"begin":106,"end":111},"obj":"Gene"},{"id":"2511","span":{"begin":169,"end":172},"obj":"Gene"},{"id":"2512","span":{"begin":178,"end":181},"obj":"Gene"},{"id":"2515","span":{"begin":66,"end":74},"obj":"Species"},{"id":"2518","span":{"begin":57,"end":65},"obj":"Disease"}],"attributes":[{"id":"A2510","pred":"tao:has_database_id","subj":"2510","obj":"Gene:3683"},{"id":"A2511","pred":"tao:has_database_id","subj":"2511","obj":"Gene:920"},{"id":"A2512","pred":"tao:has_database_id","subj":"2512","obj":"Gene:925"},{"id":"A2515","pred":"tao:has_database_id","subj":"2515","obj":"Tax:9606"},{"id":"A2518","pred":"tao:has_database_id","subj":"2518","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Interestingly, a recent study suggests that severely ill COVID-19 patients had lower levels of activated (CD11a+) and terminally differentiated (CD57+) peripheral blood CD4+ and CD8+ T cells (which are also S-protein reactive)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T647","span":{"begin":0,"end":227},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Interestingly, a recent study suggests that severely ill COVID-19 patients had lower levels of activated (CD11a+) and terminally differentiated (CD57+) peripheral blood CD4+ and CD8+ T cells (which are also S-protein reactive)."}